$16.18
3.29% yesterday
Nasdaq, Jun 12, 10:00 pm CET
ISIN
US74587B1017
Symbol
PLSE

Pulse Biosciences, Inc. Stock price

$16.18
-0.61 3.63% 1M
-0.96 5.60% 6M
-1.23 7.06% YTD
+2.81 21.02% 1Y
+7.86 94.47% 5Y
+12.01 288.01% 10Y
+12.01 288.01% 20Y
Nasdaq, Closing price Thu, Jun 12 2025
-0.55 3.29%
ISIN
US74587B1017
Symbol
PLSE
Sector

Key metrics

Market capitalization $1.09b
Enterprise Value $969.21m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 9.19
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-63.69m
Free Cash Flow (TTM) Free Cash Flow $-40.25m
Cash position $119.28m
EPS (TTM) EPS $-0.89
Short interest 15.55%
Show more

Is Pulse Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

Pulse Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Pulse Biosciences, Inc.:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Pulse Biosciences, Inc.:

Hold
100%

Financial data from Pulse Biosciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 26 26
63% 63%
-
- Research and Development Expense 36 36
25% 25%
-
-63 -63
44% 44%
-
- Depreciation and Amortization 1.16 1.16
3% 3%
-
EBIT (Operating Income) EBIT -64 -64
43% 43%
-
Net Profit -60 -60
42% 42%
-

In millions USD.

Don't miss a Thing! We will send you all news about Pulse Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pulse Biosciences, Inc. Stock News

Neutral
Business Wire
21 days ago
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to four new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, ...
Neutral
Seeking Alpha
about one month ago
Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor - Gilmartin Group Jon Skinner – CFO Paul LaViolette – CEO and Co-Chairman of the Board Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to the Pulse Biosciences First Quarter 2025 Financial Results Conference Call. At this time all lines a...
Neutral
Business Wire
about one month ago
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates and financial results for the first quarter ended March 31, 2025. Recent Business Highlights Soft Tissue Ablation Expanded direct commercial resources for the launch of t...
More Pulse Biosciences, Inc. News

Company Profile

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Head office United States
CEO Paul LaViolette
Employees 75
Founded 2014
Website www.pulsebiosciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today